drugset / Trial / NCT01229410
Pharmacokinetics of the Brimonidine Tartrate Posterior Segment Delivery System in Patients Undergoing Pars Plana Vitrectomy
RandomizedParallel-groupDouble-blindBasic science
Summary
This study will evaluate the pharmacokinetics of brimonidine following a single intravitreal administration of the 200 ug or 400 ug Brimonidine Tartrate Posterior Segment Drug Delivery System in patients 2, 4 or 8 weeks prior to undergoing a pars plana vitrectomy.
Timeline
- Start
- 2010-12
- Primary completion
- 2011-05
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brimonidine | Small molecule | 200 ug | Intravitreal |
| Subject | Brimonidine | Small molecule | 400 ug | Intravitreal |
Indications
No indication recorded.